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The CASTOR (CST) transcription factor was initially
identified for its role in maintaining stem cell compe-
tence in the Drosophila dorsal midline. Here we
report that Xenopus CST affects cardiogenesis. In
CST-depleted embryos, cardiomyocytes at the ven-
tral midline arrest and are maintained as cardiac
progenitors, while cells in more dorsal regions of
the heart undergo their normal program of differenti-
ation. Cardia bifida results from failed midline differ-
entiation, even though cardiac cell migration and
initial cell fate specification occur normally. Our fate
mapping studies reveal that this ventral midline pop-
ulation of cardiomyocytes ultimately gives rise to the
outer curvature of the heart; however, CST-depleted
midline cells overproliferate and remain a coherent
population of nonintegrated cells positioned on the
outer wall of the ventricle. These midline-specific
requirements for CST suggest the regulation of car-
diomyocyte differentiation is regionalized along a
dorsal-ventral axis and that this patterning occurs
prior to heart tube formation.
INTRODUCTION
Terminal differentiation of progenitor populations is initiated in
response to alterations in growth factor signaling, which leads
to an arrest in cell cycle progression and the transcription of tis-
sue-specific genes. In contrast to other cell types such as neural
tissue and skeletal muscle, relatively little is known about the
molecular pathways that trigger the onset of cardiomyocyte dif-
ferentiation during heart development. Studies in tissue culture
focusing on the ability of growth factors to drive the formation
of cardiomyocytes from stem cells have identified numerous
pathways that may be involved in cardiomyocyte differentiation
(Guan and Hasenfuss, 2007; Liu et al., 2007); however, the tran-
scriptional targets of these pathways or the endogenous role for
their components during in vivo embryonic cardiomyocyte differ-
entiation remains unclear. Furthermore, it is not known whether
cardiomyocytes differentiate in a uniform manner in response
to a single cue or if specific subsets of cardiomyocytes differen-
tiate in response to different pathways.616 Developmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc.To address these issues and to begin to identify the molecular
pathways that function in vivo to regulate the onset of car-
diomyocyte differentiation, we have characterized the Xenopus
ortholog of Castor (Cst), a protein that regulates stem cell com-
petence in Drosophila (Cui and Doe, 1992; Mellerick et al.,
1992). In this report, we show that vertebrate Cst is expressed
in themyocardial layer of the heart in a dorsal-to-ventral gradient
and demonstrate that CST is required within a subset of cardiac
progenitor cells for the initiation of cardiomyocyte differentiation
at the ventral midline. Fate mapping of cardiac tissue indicates
that cardiac progenitors at the ventral midline have a specific
cell fate, giving rise to a population of cells in the outer curvature
of the ventricle. In contrast, ventral midline cells depleted of CST
overproliferate and fail to integrate into cardiac muscle. Collec-
tively, these studies demonstrate that CST is required for the
proper timing of differentiation within a subset of cardiac progen-
itors that are fated to give rise to the outer curvature of the
ventricle, and suggest that regulation of cardiomyocyte differen-
tiation is regionalized along a dorsal-ventral axis prior to heart
tube formation.
RESULTS
Cst Is Expressed in the Myocardium Prior to the Onset
of Cardiomyocyte Differentiation
To begin to identify the molecular pathways that are involved in
the decisions of cardiac progenitor cells to proliferate or differen-
tiate, we have focused on the vertebrate orthologs of Castor
(Cst), a known regulator of stem cell competence in Drosophila.
We have identified two alternatively 5-prime-spliced variants of
vertebrate Castor (Csta and Cstb) from Xenopus laevis (X. laevis)
as well as Xenopus tropicalis (X. tropicalis) (Figure 1A; see
Figure S1A in the Supplemental Data available with this article
online). Synteny and sequence analysis confirmed that these
are the true orthologs of jawed vertebrate and Drosophila Castor
(Figures S1B–S1D). In vitro translation of CSTa and CSTb give
proteins of the expected size (Figure S1E) and injection of
mRNAs into Xenopus show CSTa and CSTb both localize to
the nucleus in Xenopus tissue (Figures S1F–S1G). RT-PCR anal-
ysis with Csta- and Cstb-specific primers (Figure S2A) indicate
Csta is expressed at the onset of neurulation (Stage 13), whereas
Cstb is expressed slightly later (Stage 15), with both transcripts
continuing to be expressed throughout embryonic development.
Using a probe common to Csta and Cstb shows a nearly identi-
cal spatial pattern of expression in X. laevis and X. tropicalis
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Heart Development
(A) Predicted schematic representation of CSTa
and CSTb proteins; nuclear localization signal (yel-
low), zinc finger repeats (red), serine-rich region
(red).
(B–F) Whole-mount in situ analysis of Stage 27
(early tailbud), Stage 32 (tailbud), and Stage 36
(early tadpole) embryos using aCst-specific probe
common to Csta and Cstb. ([B], lateral view with
anterior to the left; [C and D] ventral and dorsal
views, respectively, with anterior to the top). (D
and F) Transverse sections of whole-mount in
situ Stage 36 embryos through (D) the heart and
(F) the hindbrain: hindbrain (hb), somites (s), heart
primordium (hp), heart (h), myocardium (m), endo-
cardium (en), commissural neurons (c).
(G–J) Representative (G and I) control MO and (H
and J) CstMO embryos. (G) Stage 32 control MO
and (H) CstMO embryos are indistinguishable. (I)
Stage 41 control MO and (J) CstMO embryos.
CST-depleted embryos present with dorsal fin
edema and no gross ventral region abnormalities.
(K) RT-PCR analysis of Stage 42 tadpoles injected
at the one-cell stage with the CstMO demonstrat-
ing inhibition of proper slicing of Cst pre-mRNA.
Control MO (Con MO) and 5-mismatch MO (5-
mis MO) are negative controls.
(L) Whole-mount MHC antibody staining of tad-
pole Stage 37 CST-depleted embryos (lateral
views with anterior to the left); inflow tract (i), ven-
tricle (v), outflow tract (o). Scale bars: (B–C) = 0.5
mm, (G) = 1 mm, (D and L) = 100 mm.(Figure 1B; Figures S2B–S2K and S3), with Cst expression first
observed at the dorsal midline in the developing hindbrain region
of the embryo (Figure S2B) (Stage 13) and by early tailbud stage
in the developing somites (Figure 1B). By early tailbud stage
(Stage 27) we also observe expression ofCst in the heart primor-
dium (Figure 1B) during the period when the bilateral heart fields
begin to fuse across the ventral midline, and at Stage 29 we find
Cst coexpressed with the cardiac maker Nkx2.5 throughout the
heart tube (Figures 1B–1C; Figure S4). On more detailed analy-
sis, we observe Cst expression within the myocardial layer of
the heart in a dorsal-to-ventral gradient (Figure 1D). We further
note that onset andmaintenance ofCst expression is not disrup-
ted in TBX5-, TBX20-, or HSP27-depleted embryos (Brown et al.,
2005, 2007), suggesting that CST is not a downstream compo-
nent of these pathways (data not shown).
CST Is Required for Heart Development
To determine the requirement for CST in development, both
CSTa and CSTb were depleted using morpholinos that block
splicing of a common conserved region of the transcripts located
between exon 8 (ex8D MO) and exon 9 (ex9A MO) (Figure S5A).
These splice junction morpholinos, referred to collectively as
CstMO, abrogate proper splicing of both pre-mRNAs and intro-
duce a stop codon after the second amino acid following exon 8.
CstMO, but not a five-nucleotide mismatched CstMO, properly
targets Cst until at least tadpole stage (Stage 42), as shown by
RT-PCRwith theCstMOgiving an amplified product that is larger
than that in control-MO-injected embryos by the size of theDcorresponding intron (679 bp) (Figure 1K). Cloning and sequenc-
ing of respective PCR bands confirmed that they were the
expected products derived from the Cst locus. Together, these
data demonstrate that CstMO depletes the embryo of CSTa
and CSTb until at least Stage 42.
Examination of CST-depleted embryos indicate that they are
indistinguishable from control MO-injected embryos until Stage
41 (Figures 1G–1J) when fluid begins to accumulate over the dor-
sal fin and they have small, compact hearts (Figure 1J). Shortly
thereafter (Stage 42), CST-depleted embryos develop ventral
edema (Figure S6) and die when sibling embryos develop to
Stage 46. Despite the normal appearance of earlier CST-
depleted tadpole-stage embryos (Stage 37) (Figures 1G–1H),
upon closer examination, CST-depleted hearts had improperly
looped, giving the overall appearance of a twisted, kinked tube
(Figure 1L) when examined by MHC staining. Cst-specific mor-
pholinos against the 50 regions of Csta and Cstb (Figure S5B)
gave identical results, confirming that the phenotype is due to
depletion of CSTa and CSTb. This strongly implies that any pro-
tein associated with the Cst splice junction morpholinos is non-
functional rather than acting as a dominant-negative protein.
These data demonstrate that CST is required for early cardiac
development in Xenopus.
CST Is Required for the Onset of Cardiomyocyte
Differentiation at the Ventral Midline
Since Cst is first expressed in heart primordium at Stage 27, the
abnormal heart morphology at tadpole Stage 37 is likelyevelopmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc. 617
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cyte Differentiation at the Ventral Midline
(A–L) Whole-mount in situ analysis with early car-
diac markers Nkx2.5 (A, B, G, and H), Tbx5 (C, D,
I, and J), and Tbx20 (E, F, K, and L) of tailbud Stage
26 and 29 control and CST-depleted embryos
(ventral view with anterior to the top). Cardiac pro-
genitors have properly migrated and completely
fused across the ventral midline.
(M–U) Whole-mount MHC antibody staining at
Stage 29 (onset of cardiac differentiation), Stage
32 (completion of linear heart tube formation),
and Stage 37 (chamber formation) (ventral view
with anterior to the top). (M) Stage 29 control MO
embryos and (N and O) CST-depleted embryos.
(P) Stage 32 control MO embryos and (Q and R)
CST-depleted embryos display varying degrees
of cardia bifida of the linear heart tube upon CST
depletion. (S) Stage 37 control MO embryos and
(T and U) CST-depleted embryos display morpho-
logical consequences of CST depletion on cham-
ber formation.
(V–Y) Whole-mount Tmy antibody staining of
Stage 29 and 32 (V and X) control MO and (W
and Y) CST-depleted embryos demonstrates that
lack of differentiation is not specific to MHC. (Z–
B0) Simultaneous detection of cardiac progenitor
cells and differentiated cardiac cells in a Stage
29 CST-depleted embryo.
(Z and A0) Whole-mount double in situ analysis us-
ing a Nkx2.5-specific probe (pink) to mark cardiac
progenitor cells and Cardiac troponin I-specific
probe (blue) to mark differentiated cardiac cells
in (Z) control MO and (A0) CST-depleted embryos.
(B0) Magnified image of the cardiac region in the
CST-depleted embryo in (A0).
(C0 and D0) Transverse sections of Stage 29 (C0)
control MO and (D0) CST-depleted embryos
stained with MHC antibody and DAPI. Brackets
highlight the lack of differentiation at the ventral
midline.
(E0) Quantification of differentiated cardiomyocytes determined by counting the total MHC-positive cells derived from serial sectioned embryos. Bars represent
the average of at least six embryos per condition ± SEM; *p < 0.01. Representative images are derived from a single experiment, and all experiments were re-
peated at least twice with independent batches of embryos. Scale bars: (G) = 0.5 mm, (S and X) = 100 mm, (C0) = 200 mm.a consequence of an earlier requirement for CST in cardiac
development. During the process of early cardiogenesis, speci-
fied cardiac progenitor cells migrate toward the ventral midline,
where they meet (Stage 26) and fuse at the ventral midline (Stage
29). Cardiomyocytes then undergo epithelialization, initiate the
expression of cardiac structural genes, and begin myofibrillo-
genesis. To determine when CST is required in heart develop-
ment, in situ analysis was performed on control and CST-
depleted embryos with a panel of early cardiac markers that
include Nkx2.5, Tbx5, Tbx20,Gata4,Gata5, andGata6. No alter-
ation in temporal or spatial expression of any of these markers
was observed between control and CST-depleted embryos up
to Stage 29 (Figures 2A–2L; Figure S7), suggesting that CST is
not required for the determination, migration, or, most critically,
fusion of cardiac precursor cells.
To determine if CST is required for cardiomyocyte differentia-
tion, whole-mount antibody staining was conducted with anti-
bodies against MHC (Figures 2M–2U) and Tropomyosin (Tmy;
Figures 2V–2Y). Although CST-depleted embryos have a single
normal-sized continuous cardiac field that uniformly expresses618 Developmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc.Nkx2.5, Tbx5, Tbx20, Gata4, Gata5, and Gata6 (Figures 2A–2L;
Figure S7), we found that CST-depleted embryos fail to initiate
cardiac differentiation at the ventral midline (Figures 2M–2O
and 2V–2W). We confirmed that the cells at the ventral midline
are Nkx2.5 positive by double whole-mount in situ analysis
with Nkx2.5- and cardiac troponin I-specific probes (Figures
2Z–2B0). Additionally, we find CST-depleted hearts have archi-
tectural defects including distention along the left-right axis in
the ventral region of the embryo (Figures 2N–2O and D0). These
results collectively suggest that CST is required within a 6 hr
period of heart development between Stage 27 and Stage 29
for proper differentiation of a subset of cardiomyocyte progeni-
tors at the ventral midline.
To verify that alteration in heart morphology in CST-depleted
embryos is associated with a failure of ventral cardiomyocytes
to undergo differentiation, we determined the total number of dif-
ferentiated cardiomyocytes in control and CST-depleted heart
tissue staining with DAPI, to mark cell nuclei, and anti-MHC, to
mark differentiated cardiomyocytes (Figures 2C0–2E0). Consis-
tent with a failure of the ventral midline cells to express MHC,
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entiated cardiomyocytes in CST-depleted hearts relative to con-
trol hearts, 525.90 ± 42.16 versus 690.5 ± 19.76, respectively
(Figure 2E0). We further note that this decrease is not a reflection
of a role for CST in cardiac cell survival since we observed no in-
crease in the total number of cardiac cells that were positive for
TUNEL or the apoptotic marker Capase-3 during these stages
(data not shown). Taken together, these data demonstrate
a role for CST in cardiac differentiation at the ventral midline
and suggest that regulation of cardiomyocyte differentiation is
regionalized along the dorsal-ventral axis.
Failure of the cardiac cells in CST-depleted embryos to uni-
formly differentiate across the ventral midline leads to a bifurca-
tion of the developing linear heart tube by slightly later stages
(Stage 32) (Figures 2Q–2R and 2Y). Similar to genetic mutants
in zebrafish which lead to cardia bifida, e.g., natter, miles apart,
mtx, and bon (Chen et al., 1996; Sakaguchi et al., 2006; Stainier
et al., 1996), severity of the bifida ranges from extreme pheno-
types (30% penetrance) (Figures 2R and 2Y), in which CST de-
pletion results in two separate linear heart tubes, to moderate
phenotypes (60% penetrance) (Figure 2Q) that manifest as two
Figure 3. CST IsNot Required for Formation
or Patterning of Endodermal Tissue
(A) Schematic representation of endodermal tissue
markers that demarcate pharyngeal endoderm
(Sox2 and Endodermin), ventral midgut (Vito and
Endodermin), and posterior endoderm (Endocut).
(B) Relative expression levels of endodermal
markers Sox2, Vito, Endodermin, and Endocut in
Stage 29 CST-depleted embryos (n = 5) relative
to control MO embryos (n = 5) using GAPDH as
the housekeeping gene.Bars represent the relative
expression levels ± SEM.
(C–F) Whole-mount in situ analysis of endodermal
markers (C) Sox2, (D) Vito, (E) Endodermin, and
(F) Endocut in Stage 29 (top) control MO and (bot-
tom) CST-depleted embryos (lateral viewswith an-
terior to the left).
(G–H) In situ analysis of endodermal and cardiac
markers on adjacent transverse sections through
the cardiac region of (top) control MO and (bottom)
CST-depleted Stage 29 embryos. (G) Sox2 and
Nkx2.5 expression on adjacent sections demon-
strating proper expression within pharyngeal tis-
sue of CST-depleted embryos. (H) Endodermin
and Tbx20 expression on adjacent sections dem-
onstrating proper relative spatial expression within
the cardiac tissue and endoderm of the embryo.
heart fields joined along the ventral mid-
line either posteriorly or along the length
of the heart field to form an irregular heart
tube. Variation in linear heart tube forma-
tion ultimately disrupts the morphogenic
movements of the heart tube, resulting
in a secondary cardiac looping defect
seen in the chambered heart (Stage 37)
(Figures 2T–2U). An identical cardiac
phenotype is observed when a combina-
tion of morpholinos targeting the 50 UTR
of Csta and Cstb is injected (Figure S5C). Taken together, these
results imply that, in contrast to other cardia bifida phenotypes,
CST depletion causes a bifurcation of the heart due to lack of uni-
form differentiation of cardiomyocytes across the midline.
CST Depletion Does Not Affect Endoderm Formation
or Patterning, Components of the Extracellular Matrix,
or Cardiac Polarity
Signals from the endoderm are required for proper cardiac
midline development (Chen et al., 1996; Stainier et al., 1996);
however, we were unable to detectCst expression within the en-
doderm or endodermal derivatives over the periods in which we
observed the phenotype in CST-depleted embryos (Figure 1B;
Figure S2). To further exclude the possibility that the inability of
cardiomyocytes to differentiate at the ventral midline in CST-de-
pleted embryos is a secondary consequence of alterations in the
formation, maintenance, or patterning of endodermal tissue,
endodermal markers Endodermin, Sox2, Endocut, and Vito
were assayed for spatial expression by in situ analysis in both
whole-mount and sectioned embryos, and for quantitative
expression by SYBR Green quantitative PCR (Figure 3). NoDevelopmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc. 619
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mal markers were observed in CST-depleted embryos, further
suggesting that CST is not required for the proper formation,
maintenance, or patterning of endodermal tissue.
To determine if CST functions in a tissue-autonomous fashion,
we assayed for alteration in components of the extracellular ma-
trix (Fibronectin and Fibrillin), cardiomyocyte polarity (b-Catenin),
and endocardium/BMP signaling (SMAD1/5/8). No alteration in
the staining pattern of any of these markers was observed be-
tween control MO and CstMO-derived hearts (data not shown).
Collectively, these data demonstrate that the midline defect as
a consequence of CST depletion is due to a block or delay in car-
diomyocyte differentiation and is not a secondary consequence
of alterations in cardiac migration or polarity. Moreover, these
results suggest that the phenotype of CST depletion is not asso-
ciated with inappropriate activation of the canonical Wnt path-
way or inactivation of the BMP2/4/7 pathway.
Fate Mapping of Cardiac Ventral Midline Cells
Collectively, our results imply cardiomyocytes at the ventral mid-
line have a fate different from that of neighboring cardiomyocyte
progenitors. To determine the ultimate fate of these cardiomyo-
cytes at the ventral midline, we conducted fate mapping studies
at the time when we first detect a phenotype in CST-depleted
embryos; i.e., when cardiac progenitors have fused at the ante-
rior ventral midline (Stage 29). Using anatomical landmarks and
a cardiac actin-GFP (CA-GFP) transgenic reporter host strain
of Xenopus to unambiguously identify cardiac tissue, we injected
MitoTracker dye into the ventral midline of control MO-injected
CA-GFP-positive embryos (Figures 4A and 4B), identified by
GFP expression in the developing somites. We then scored em-
bryos that incorporated the dye into the underlying mesoderm.
Broadly consistent with studies in chick (Abu-Issa and Kirby,
2007; De La Cruz et al., 1989; Moreno-Rodriguez et al., 2006),
we find that by the stage at which the heart initiates chamber
morphogenesis, cardiomyocytes derived from the ventral mid-
line give rise to cells that occupy positions in the medial outer
curvature of the heart (Stage 35) (Figures 4C and 4E–4I). At later
stages, during the period after completion of chamber and valve
formation (Stage 45), cells preferentially colonize the outer cur-
vature of the mature ventricle and, to a lesser extent, the atrium
(Figures 4D and 4V–4Z).
CST-Depleted Cardiac Ventral Midline Cells Fail
to Integrate into the Mature Heart
To further establish the role of CST in cardiac midline develop-
ment, and to confirm that cells that occupy a position in cardiac
ventral midline in CST-depleted embryos are cardiomyocyteprogenitors, we fate mapped ventral midline cells in CA-GFP
embryos in which we depleted CST. In stark contrast to results
from wild-type embryos, ventral midline cells in CST-depleted
embryos preferentially give rise to cells that occupy positions
in the posterior midline of the developing heart (Figures 4D and
4J–4N). Interestingly, we also found a portion of fated CST-de-
pleted ventral midline cells located in a posterior undifferentiated
ventricular cleft (Figures 4O–4U). Although we often observe that
CST-depleted ventral midline cells are delayed but not blocked
in cardiomyocyte differentiation, in all case cells fail to integrate
into the heart and remain as a condensed population of cells
attached to the outer ventricular wall (Figures 4D and 4V–4Z).
CST Is Required for the Regulation of Cardiomyocyte
Proliferation
We observe from our fate mapping studies at later stages that
CST-depleted, labeled ventral midline cells consistently give
rise to a much larger population of cells relative to controls (com-
pare Figure 4Y with 4D0). Consistent with this observation, we
find cardiomyocytes undergoing differentiation in the more
dorsal regions of the CST-depleted hearts have a significantly
increased mitotic index (Figure S8). Collectively, these data im-
ply that CST plays a critical role in regulating the proliferation
and onset of differentiation of cardiac progenitors.
DISCUSSION
Our findings collectively imply that cardiomyocytes do not differ-
entiate in a uniform manner and strongly suggest that cells in the
ventral region of the heart field differentiate in response to local-
ized signals. Our results further imply that cardiomyocytes differ-
entiate along a dorsal-ventral axis before the onset of terminal
cardiomyocyte differentiation; thus, cardiac progenitor fates
appear to be determined prior to the formation of the linear heart
tube.
We observe that the requirement for CST in cardiomyocyte
differentiation is within a subset of cardiac progenitor cells in
which Cst is expressed. What then limits CST function to the
ventral midline? One possibility is that CST functions redun-
dantly with other transcription factors in regulating cardiomyo-
cyte differentiation in more dorsal regions of the heart; however,
CST binds DNA through a unique para-zinc finger domain
(Mellerick et al., 1992). Similar to studies in Drosophila, we are
unable to identify any protein in the genomes of Xenopus, chick,
or mammals that contains a similar domain, suggesting that CST
acts on an exclusive set of transcriptional targets. Based on
these observations, our phenotypic analysis of cardiac tissue
depleted of CST, and by inference with Drosophila (KambadurFigure 4. Fate Mapping Cardiac Ventral Midline Cells
(A) Bright-field image of a living cardiac actin-GFP transgenic embryo injected with MitoTracker at Stage 29 along the ventral midline 5.5 mm posterior to the
cement gland (CG). (B) Fluorescent image of the same embryo demonstrating the location of incorporated MitoTracker into cells at the ventral midline (ventral
views with anterior to the top). Fluorescence anterior to site of injection is reflection off the surface of the live embryo. (C and D) Tabulation of the location of
MitoTracker-labeled cardiac cells of control MO and CST-depleted embryo at (C) midtailbud Stage 35 and (D) tadpole Stage 45. Images of CA-GFP transgenic
control MO-injected andCST-depleted (E–H, J–M, andO–U) Stage 35 and (V–Y and A0–D0) Stage 45 dissected hearts. (F, K, P, T, U, and Z) Corresponding images
of GFP expression. (G, L, Q, X, and C0) Corresponding images of fated MitoTracker-labeled cardiac ventral midline cells. (H, M, R, U, Y, and D0) Merged images of
GFP and fated MitoTracker-labeled ventral midline cells. (T and U) Note the fated ventral midline cells in a pocket of undifferentiated (GFP-negative) cardiomyo-
cytes. (I, N, S, Z, and E0) Schematics representing fate of the cardiac ventral midline cells to the outer curvature of the ventricle in (I) Stage 35 and (Z) Stage 45
control MO-injected hearts. CST-depleted fated ventral midline cells located in the (N) posterior midline or (S) in an undifferentiated cleft in the outer ventricular
myocardium in Stage 35 CST-depleted hearts and (E0) in a condensed mass of cells on the outer ventricle in Stage 45 CST-depleted hearts.Developmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc. 621
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yet unidentified factors. Consistent with this proposal, we have
shown that overexpression of CST throughout the embryo leads
to cellular defects only in tissue types that normally express CST
(data not shown).
We note that our fate mapping studies of early Xenopus hearts
are consistent with those performed in chick showing that car-
diac progenitors at the ventral midline preferentially give rise to
terminally differentiated cardiomyocytes in the outer ventricular
wall (De La Cruz et al., 1989; Moreno-Rodriguez et al., 2006).
Studies in chick further demonstrated that cardiomyocyte
progenitors at the ventral midline are derived from the cephalic
mesoderm; i.e., the anterior heart field. Therefore, it is intriguing
to speculate that the regulation of CST activity restricts its role to
cardiac cells derived from the anterior heart field.
In light of the role for CST in cardiac differentiation and its high
degree of sequence conservation and expression between
vertebrates (Liu et al., 2006; Vacalla and Theil, 2002), it will be
interesting in the future to examine the relationship between
CST and congenital heart disease and cardiac hypertrophy.
EXPERIMENTAL PROCEDURES
Embryo Collection, Cst Cloning, and Morpholinos
Preparation and collection of X. tropicalis and X. laevis were performed as
described (Showell et al., 2006) and staged according to Nieuwkoop and
Faber (1967). Cst-specific morpholinos were obtained from Gene Tools,
LLC. Sequences of all morpholinos are available upon request. To demon-
strate morpholino efficacy, RNA was extracted from homogenized Stage 42
tadpoles in lysis buffer (Goetz et al., 2006) followed by RT-PCR as described
in Supplemental Experimental Procedures.
Developmental Whole-Mount In Situ Hybridization
Whole-mount in situ analysis and double detection whole-mount in situ analy-
sis was carried out as described (Harland, 1991) using a-sense RNA probes of
Nkx2.5 (Tonissen et al., 1994), Tbx5 (Horb and Thomsen, 1999), Tbx20 (Brown
et al., 2003), cardiac troponin I (Logan and Mohun, 1993), Sox2 (Kishi et al.,
2000), Endodermin (Langdon et al., 2007), Endocut (Costa et al., 2003), and
Vito (Xenopus EST clone XL043k17 [Costa et al., 2003]). For double in situs
the protocol was modified so embryos were simultaneously analyzed with flu-
orosceine-labeled Nkx2.5 probe and either Cst or cardiac troponin I DIG-la-
beled probe. Following incubation with a-fluorosceine alkaline phosphatase
antibody, Nkx2.5 expression was detected using 175 mg/ml of magenta phos-
phate and 225 mg/ml tetrazolium red in AP buffer at 4C for 3–5 days. Embryos
were washed three times in PBS incubated in 0.1M glycine-HCl (pH 2.2), 0.1%
Tween-20 for 10 min at RT. DIG-labeled probes were detected as described.
Embryos were bleached then photographed on a LeicaMZF III fluorescent dis-
secting microscope. Stained embryos were prepared for 20 mm frozen sec-
tioning in OTC freezing media. Sections were rinsed with PBS, coverslipped,
and imaged on a Zeiss Axiovert 35 microscope.
Immunohistochemistry
Immunohistochemistry was carried out with mouse anti-Myosin Heavy Chain,
mouse anti-Tropomyosin (Developmental Studies Hybridoma Bank), and rab-
bit anti-phospho-histone H3 (Cell Signaling) using Cy3 anti-rabbit, Cy3 anti-
mouse, and Alexa 488 anti-mouse as described (Goetz et al., 2006). Embryos
were cleared in 2:1 benzyl benzoate:benzyl alcohol and viewed on a Leica
MZFIII fluorescence dissecting microscope. Sections were imaged on a Nikon
Eclipse E800 fluorescent microscope.
SYBR Green Quantitative PCR
RNA was isolated from Stage 29 embryos (ten embryos per condition) using
Trizol (Invitrogen) and purified using an RNeasy column (QIAGEN) according
to the manufacture’s protocol. cDNA synthesis with 1 mg of RNA was per-622 Developmental Cell 14, 616–623, April 2008 ª2008 Elsevier Inc.formedwith randomprimers using SuperScript II reverse transcriptase (Invitro-
gen) according to the manufacture’s protocol. Expression levels were
assessed by quantitative PCR using SYBR Green Master Mix (Sigma) on
a Rotogene 3000. Primers (19–21 bp) were designed for eachmRNA to amplify
a 100–121 bp product. Prior to quantitative PCR analysis, primer sets were
tested by standard PCR and analyzed by 2.5% agarose gel electrophoresis
to determine amplification of a single PCR product. GAPDH was used as the
housekeeping gene. Reactions with 5 ml of a 1:60 dilution of the cDNA were
heated to 94 for 2 min, followed by 50 cycles of 94C, 15 s; 55C, 15 s;
72C, 20 s. Following amplification, melting curves were generated to verify
the presence of a single amplification product. Each sample was analyzed in
triplicate with a corresponding minus-RT control. Five samples (n = 5) per
condition were analyzed. Analysis generated Ct values based on thresholds
determined by Rotogene 3000 software. Data were analyzed by the Pfaffl
method (Pfaffl et al., 2002) and represented as relative fold change ± SEM.
Fate Mapping
Fertilized embryos were injected at the one-cell stage with either Cst MOs or
control MOs as described (Goetz et al., 2006). Stage 29 GFP-positive embryos
were embedded in 3% methyl-cellulose and injected with 0.3 nl of 1 mM Mito
Tracker Red CMXRos (Molecular Probes) at the ventral midline 5.5 mm from
the posterior boundary of the cement gland. Two hours postinjection, embryos
were analyzed and scored for incorporation into GFP-positive cardiac tissue.
Stage 35 and 45 hearts were dissected in 13Modified Barths Solution (MBS)
and placed in 13 MBS supplemented with 0.1 M KCl to arrest contraction.
Stage 35 labeled clones were scored based on anterior-posterior axis and
inner-outer curvature of the heart, and Stage 45 based on location of labeled
clones in the atrium or ventricle. Transgenic animals expressing cardiac actin-
GFP were a generous gift from Dr. Tim Mohun (Latinkic et al., 2002).
Statistical Methods
Morpholino injections were performed on >15 batches of embryos. Similar
results were seen in each experiment. Statistical differences of cell counts
between injected embryos were determined using one-tailed, unpaired t tests.
The number of embryos used in each experiment is noted in the results.
ACCESSION NUMBERS
Sequences of X. laevis Csta, X. laevis Cstb, X. tropicalis Csta, and X. tropicalis
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